These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 28739692

  • 1. WNT/β-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
    Urushibara S, Tsubota T, Asai R, Azumi J, Ashida K, Fujiwara Y, Shiota G.
    Anticancer Res; 2017 Aug; 37(8):4085-4091. PubMed ID: 28739692
    [Abstract] [Full Text] [Related]

  • 2. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S, Miao D, Wang M, Lv J, Wang Y, Tong J.
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [Abstract] [Full Text] [Related]

  • 3. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q, Li XT, Chen Y, Chen JQ, Zhu JY, Meng Y, Wang XQ, Li Y, Geng SS, Xie CF, Wu JS, Zhong CY, Han HY.
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [Abstract] [Full Text] [Related]

  • 4. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q, Yang T, Li D, Ding F, Bai G, Wang W, Sun H.
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [Abstract] [Full Text] [Related]

  • 5. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q, Yao G, Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Shi J, Li H, Zhang Y, Liu H.
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [Abstract] [Full Text] [Related]

  • 6. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y, Shiota G.
    Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
    [Abstract] [Full Text] [Related]

  • 7. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.
    Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Il Kim T, Clevers H, Choi KY.
    Nat Commun; 2020 Oct 21; 11(1):5321. PubMed ID: 33087710
    [Abstract] [Full Text] [Related]

  • 8. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
    Venugopal A, Subramaniam D, Balmaceda J, Roy B, Dixon DA, Umar S, Weir SJ, Anant S.
    Mol Carcinog; 2016 Nov 21; 55(11):1503-1516. PubMed ID: 26331352
    [Abstract] [Full Text] [Related]

  • 9. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells.
    Klose J, Eissele J, Volz C, Schmitt S, Ritter A, Ying S, Schmidt T, Heger U, Schneider M, Ulrich A.
    BMC Cancer; 2016 Nov 17; 16(1):896. PubMed ID: 27855654
    [Abstract] [Full Text] [Related]

  • 10. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L, Li Y, He B, Gong Y.
    Clin Colorectal Cancer; 2015 Sep 17; 14(3):133-45. PubMed ID: 25799881
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G, Lin J, Wang W, Sun M, Chen K, Wang F.
    Genet Test Mol Biomarkers; 2017 Feb 17; 21(2):74-79. PubMed ID: 28051879
    [Abstract] [Full Text] [Related]

  • 17. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M, Bouygues A, Ouaret D, Ferrand N, Chouaib S, Thiery JP, Muchardt C, Sabbah M, Larsen AK.
    Oncotarget; 2015 Jul 30; 6(21):18518-33. PubMed ID: 26041882
    [Abstract] [Full Text] [Related]

  • 18. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT, Rao YK, Ye M, Wu WS, Chang TC, Wang LS, Wu CH, Wu AT, Tzeng YM.
    Toxicol Appl Pharmacol; 2012 May 15; 261(1):31-41. PubMed ID: 22465936
    [Abstract] [Full Text] [Related]

  • 19. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X, Pan Q, Lu Y, Jiang X, Zhang S, Wu J.
    Cell Biol Int; 2019 Apr 15; 43(4):402-408. PubMed ID: 30614606
    [Abstract] [Full Text] [Related]

  • 20. Tumor-suppressive zinc finger protein 24 (ZNF24) sensitizes colorectal cancer cells to 5-fluorouracil by inhibiting the Wnt pathway and activating the p53 signaling.
    Meng F, Ai C, Yan G, Wang G.
    Exp Cell Res; 2023 Dec 01; 433(1):113796. PubMed ID: 37774763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.